{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:20:41Z","timestamp":1751430041035,"version":"3.41.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.brachy.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:52:46Z","timestamp":1743792766000},"page":"524-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term rectal patient-reported quality of life outcomes among patients treated with Pd-103 LDR prostate brachytherapy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-7245","authenticated-orcid":false,"given":"Keara","family":"English","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanmay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-0690","authenticated-orcid":false,"given":"Michael","family":"Roumeliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-117X","authenticated-orcid":false,"given":"Ulysses Grant","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayane","family":"Yenokyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emerson","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"McNutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"DeWeese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-8677","authenticated-orcid":false,"given":"Daniel Y","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.brachy.2025.02.003_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.brachy.2025.02.003_bib0002","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41585-018-0060-7","article-title":"Landmarks in prostate cancer","volume":"15","author":"Sathianathen","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.brachy.2025.02.003_bib0003","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2013.09.026","article-title":"Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival","volume":"110","author":"Heemsbergen","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.02.003_bib0004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2025.02.003_bib0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ju.0000111844.95024.74","article-title":"Prostate cancer radiotherapy dose response: an update of the fox chase experience","volume":"171","author":"Pollack","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.brachy.2025.02.003_bib0006","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.brachy.2025.02.003_bib0007","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4111\/kju.2015.56.9.637","article-title":"Difference in the rate of rectal complications following prostate brachytherapy based on the prostate-rectum distance and the prostate longitudinal length among early prostate cancer patients","volume":"56","author":"Kang","year":"2015","journal-title":"Korean J Urol"},{"issue":"3","key":"10.1016\/j.brachy.2025.02.003_bib0008","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijrobp.2019.02.056","article-title":"Long-term patient-reported rectal bleeding and bowel-related quality of life after Cs-131 prostate brachytherapy","volume":"104","author":"Ling","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.brachy.2025.02.003_bib0009","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ijrobp.2020.11.023","article-title":"Impact of high-dose-rate and low-dose-rate brachytherapy boost on toxicity, functional and cancer outcomes in patients receiving external beam radiation therapy for prostate cancer: A national population-based study","volume":"109","author":"Parry","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.02.003_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2021.12.047","article-title":"UROGEC group of GEC ESTRO with endorsement by the European Association of Urology. GEC-ESTRO ACROP prostate brachytherapy guidelines","volume":"167","author":"Henry","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.02.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109599","article-title":"Outcomes after PD-103 versus I-125 for low-dose-rate prostate brachytherapy monotherapy: an international, multi-institutional study","volume":"183","author":"Tang","year":"2023","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2025.02.003_bib0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5114\/jcb.2022.119427","article-title":"Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review","volume":"14","author":"Tohidinezhad","year":"2022","journal-title":"J Contemp Brachytherapy"},{"issue":"2","key":"10.1016\/j.brachy.2025.02.003_bib0013","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.brachy.2017.11.007","article-title":"Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: results of a prospective phase II study","volume":"17","author":"Blanchard","year":"2018","journal-title":"Brachytherapy"},{"issue":"12","key":"10.1016\/j.brachy.2025.02.003_bib0014","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/iju.14090","article-title":"Quality of life outcomes after low-dose-rate brachytherapy for localized prostate cancer: current status and future perspectives","volume":"26","author":"Murakami","year":"2019","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.brachy.2025.02.003_bib0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0360-3016(03)00501-7","article-title":"Late rectal function after prostate brachytherapy","volume":"57","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2025.02.003_bib0016","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijrobp.2015.05.014","article-title":"Urinary and rectal toxicity profiles after permanent Iodine-125 implant brachytherapy in Japanese men: Nationwide J-POPS multi-institutional prospective cohort study","volume":"93","author":"Ohashi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.brachy.2025.02.003_bib0017","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.brachy.2016.04.002","article-title":"Comparative study of late rectal toxicity in prostate cancer patients treated with low-dose-rate brachytherapy: with or without supplemental external beam radiotherapy","volume":"15","author":"Serrano","year":"2016","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.brachy.2025.02.003_bib0018","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.brachy.2011.11.002","article-title":"A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer","volume":"11","author":"Kollmeier","year":"2012","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.brachy.2025.02.003_bib0019","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.brachy.2022.04.006","article-title":"Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost","volume":"21","author":"Kollmeier","year":"2022","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2025.02.003_bib0020","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.ijrobp.2018.07.255","article-title":"Palladium-103 (Pd-103) prostate cancer brachytherapy: long-term outcomes in over 700 patients","volume":"102","author":"Peach","year":"2018","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"6","key":"10.1016\/j.brachy.2025.02.003_bib0021","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5114\/jcb.2018.81024","article-title":"Brachytherapy for localized prostate cancer in the modern era: a comparison of patient-reported quality of life outcomes among different techniques","volume":"10","author":"Morgan","year":"2018","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2025.02.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109599","article-title":"Outcomes after PD-103 versus I-125 for low-dose-rate prostate brachytherapy monotherapy: an international, multi-institutional study","volume":"183","author":"Tang","year":"2023","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:12:03Z","timestamp":1751397123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1538472125000339"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.02.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term rectal patient-reported quality of life outcomes among patients treated with Pd-103 LDR prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}